A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

No one is an island: Managing post-acute care in the 21st century

by Steve Burrill, Vice Chairman, US Health Care Providers Leader, Deloitte LLP

A physician executive recently said that post-acute care has long been an archipelago of small islands, with no bridges, poor transportation, and limited communication options to the rest of the health care system.1 When someone needs rehabilitation or additional services after a hospital stay, there currently is little rhyme or reason as to why a patient is discharged to a skilled nursing facility (SNF),

Read more

Skin in the game: Innovations in boosting immunity and fighting off pathogens

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Skin is the largest organ, and scientists are discovering new ways to harvest the healthy bacteria that lives on our skin to help fight harmful bacteria. A team at the University of California, San Diego is in the early stages of developing and testing skin creams that may guard patients with eczema against risky bacteria that gather on cracked skin.

Read more

What does the new administration mean for life sciences companies?

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

Shortly after the election, the life sciences industry was wondering what was coming next. President Trump had not mentioned federal negotiation of Medicare drug prices in a while, state efforts to pass pricing legislation had failed, the outgoing Obama Administration had announced it would not move forward with the demonstration for regulating physician-administered drugs under Medicare Part B,

Read more

Deepening patient relationships and improving data capabilities

by David Rosner, Principal, Deloitte Consulting LLP

After years of engaging primarily with physicians, many pharmaceutical companies are making a significant shift by starting to focus their commercial activities on building relationships directly with patients. Companies with highly specialized and rare disease therapies often have had this focus longer. But now many companies, including those with diversified portfolios, are looking for ways to add value along the continuum of patient care.

Read more

Startup aims to build a blood pressure sensor into smart phones

by Doug Beaudoin, Principal, Deloitte Consulting LLP

A Swiss medical device company startup is designing a sensor that uses a smartphone to monitor and report on heart rate, respiration rate, blood oxygenation, temperature, and blood pressure. Leman Micro Devices is starting trials to submit the device for clearance with several regulators around the world and wants to license the technology to major smartphone companies to integrate the sensors into their phones within a few years.

Read more